Department of Information Systems, University of Malaya, Kuala Lumpur, Malaysia.
Division of Neurology, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
JMIR Mhealth Uhealth. 2021 May 28;9(5):e22489. doi: 10.2196/22489.
Patients with epilepsy (PWEs) are motivated to manage and cope with their disorder themselves (ie, self-management [SM] is encouraged). Mobile health (mHealth) apps have multiple features that have a huge potential to improve SM of individuals with chronic disorders such as epilepsy.
This study aimed to review all freely available apps related to the SM of PWEs and to determine the SM domains covered in these apps.
We performed a search of apps on Google Play and App Store using the keywords "epilepsy" or "seizures" from May to August 2018. Apps were included if they were free and in English language. We excluded apps with installation-related issues and not related to epilepsy self-management (eSM).
A total of 22 eSM apps were identified in our search: 6 of these run only on iOS, 7 only on Android, and 9 run on both operating systems. Of the 11 domains of SM, seizure tracking and seizure response features were covered by most apps (n=22 and n=19, respectively), followed by treatment management (n=17) and medication adherence (n=15). Three apps (Epilepsy Journal, Epilepsy Tool Kit, and EpiDiary) were installed more than 10,000 times, with features focused specifically on a few domains (treatment management, medication adherence, health care communication, and seizure tracking). Two apps (Young Epilepsy and E-Epilepsy Inclusion) covered more than 6 SM domains but both had lower installation rates (5000+ and 100+, respectively).
Both Android and iOS mHealth apps are available to improve SM in epilepsy, but the installation rate of most apps remains low. The SM features of these apps were different from one another, making it difficult to recommend a single app that completely fulfills the needs of PWEs. The common features of the apps evaluated included seizure tracking and seizure response. To improve the efficacy and availability of these apps, we propose the following: (1) involve the stakeholders, such as physicians, pharmacists, and PWEs, during the development of mHealth apps; (2) assess the efficacy and acceptance of the apps objectively by performing a usability analysis; and (3) promote the apps so that they benefit more PWEs.
癫痫患者(PWEs)有动力自行管理和应对疾病(即鼓励自我管理[SM])。移动健康(mHealth)应用程序具有多种功能,具有极大的潜力可以改善癫痫等慢性疾病患者的自我管理。
本研究旨在回顾所有与 PWEs 的 SM 相关的免费可用应用程序,并确定这些应用程序涵盖的 SM 领域。
我们于 2018 年 5 月至 8 月在 Google Play 和 App Store 上使用“epilepsy”或“seizures”等关键词进行了应用程序搜索。如果应用程序是免费的且为英文,则将其纳入。我们排除了与安装相关的问题和与癫痫自我管理(eSM)无关的应用程序。
我们的搜索共确定了 22 个 eSM 应用程序:其中 6 个仅在 iOS 上运行,7 个仅在 Android 上运行,9 个在两个操作系统上运行。在 SM 的 11 个领域中,癫痫发作追踪和癫痫发作响应功能被大多数应用程序涵盖(分别为 n=22 和 n=19),其次是治疗管理(n=17)和药物依从性(n=15)。有 3 个应用程序(《癫痫杂志》《癫痫工具包》和《癫痫日记》)的安装次数超过 10,000 次,其功能专门针对少数几个领域(治疗管理、药物依从性、医疗保健沟通和癫痫发作追踪)。有 2 个应用程序(《年轻癫痫》和《电子癫痫包容》)涵盖了超过 6 个 SM 领域,但两者的安装率都较低(分别为 5000+和 100+)。
Android 和 iOS mHealth 应用程序均可改善癫痫患者的 SM,但大多数应用程序的安装率仍然较低。这些应用程序的 SM 功能彼此不同,因此很难推荐一个完全满足 PWE 需求的单一应用程序。评估的应用程序的共同特点包括癫痫发作追踪和癫痫发作响应。为了提高这些应用程序的有效性和可用性,我们建议:(1)在开发 mHealth 应用程序时,让利益相关者(如医生、药剂师和 PWEs)参与其中;(2)通过进行可用性分析客观评估应用程序的疗效和接受度;(3)推广应用程序,使更多的 PWE 受益。